SCHEMBL22947481

SCHEMBL22947481

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4-c4ccc5c(c4)[Si](c4ccccc4)(c4ccccc4)c4ccccc4-5)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
ADORA2A P29274 3/20 0.36
ADORA1 P30542 3/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2B P29275 2/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.34
NTSR1 P30989 1/20 0.33
LMNA P02545 3/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
ATM Q13315 2/20 0.31
APAF1 O14727 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949597 0.99 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947694 0.93 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22572812 0.93 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22572806 0.93 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22949336 0.93 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947367 0.91 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947513 0.91 L3MBTL1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22949558 0.91 MEN1 (0.35) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22949664 0.90 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947250 0.89 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MEN1 2439/4885KMT2A 2115/4885MAPT 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.